Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinibJan A. Burger, Nicholas Chiorazzi, Kelvin W. Li et al.|JCI Insight|2017Cited by 93
Functional Evidence from Deuterated Water Labeling That the Bruton Tyrosine Kinase Inhibitor Ibrutinib Blocks Leukemia Cell Proliferation and Trafficking and Promotes Leukemia Cell Death in Patients with Chronic Lymphocytic Leukemia and small Lymphocytic LymphomaJan A. Burger, Nicholas Chiorazzi, Kelvin W. Li et al.|Blood|2014Cited by 11
Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosisRojo Ratsimandresy, Mark S. Wilson, Daqi Xu et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0